Contact

Mauro.Ferrari@uth.tmc.edu
Tel: 713-500-2444
Fax: 713-500-2462

Executive Assistant
Ms. Freddie Fegans
Tel: 713-500-2470
Fax: 713-500-2462
freddie.m.fegans@uth.tmc.edu

Education:

• Ph.D. Mechanical Engineering, University of California, Berkeley, 1989.
• Dottore, Mathematics, Universita’ di Padova, Italy, 1985.
• Medical Student, Ohio State University, 2002-2004.
• Biographical Sketch

Summary:

Dr. Mauro Ferrari is Professor and Director of The Division of NanoMedicine and Deputy Chairman of The University of Texas Department of Biomedical Engineering at The University of Texas Health Science Center at Houston. Dr. Ferrari is a Professor of Experimental Therapeutics at The University of Texas M.D. Anderson Cancer Center and a Professor of Bioengineering at Rice University. He is also the President of Alliance for NanoHealth.

Dr. Ferrari has held several academic appointments at previous institutions. At The University of California at Berkeley, Dr. Ferrari was a tenured Associate Professor of the Materials Science and Civil Engineering Departments. At The Ohio State University, he served as the Edgar Hendrickson Designated Chair in Biomedical Engineering and also held appointments in Mechanical Engineering, and Internal Medicine, Division of Hematology and Oncology.

Dr. Ferrari is an internationally recognized expert in the development, refinement and application of biomedical nanotechnology. He was trained in mathematics, engineering and medicine. He has published approximately 200 peer-reviewed articles. He received many national and international awards including the James A. Shannon Director's Award from the National Institute of Health, elected Fellow of the American Institute of Medical and Biological Engineering (AIMBE), received the Department of Defense (DOD) Breast Cancer Research Program (BCRP) Innovator Award in 2008, National Young Investigator Award of National Science Foundation from 1993 to 1998 and the Wallace H. Coulter Award for Innovation and Entrepreneurship in 1999. Dr Ferrari was also the first recipient of a Research Superiority Award of the Emerging Technology Fund of the State of Texas. From 2003 to 2005, he served as Special Expert on Nanotechnology and Eminent Scholar at The National Cancer Institute, where he led in the development of the NCI's program in Nanotechnology, which remains the largest program in NanoMedicine in the world. Dr. Ferrari currently serves as the Editor-in-Chief for “Biomedical Microdevices: BioMEMS and Biomedical Nanotechnology” since 1997.

Dr. Ferrari has more than 30 U.S. and International patents awarded to his credit and has founded several startup companies. Furthermore, he is the scientific founder of NanoMedical Systems (NMS) in Austin, Texas and Leonardo Biosystems. He also currently serves as the Director of Scientific Strategy at the Arrowhead Research Corporation (NASDAQ:ARWR).